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osting by EAbstract In this study, a nereistoxin analogue insecticide, thiocyclam, was administered to adult
male albino rats by gavage dose of 135, 270 and 540 mg/kg b.w. repeated for 5 days at 24 h inter-
vals. Control animals received only water. Thiocyclam was tested for its potential to cause geno-
toxic effects in rat bone marrow cells using an in vivo micronucleus assay. After 24 h of the last
treatment, rats from all dose levels were sacriﬁced. Bone marrow cells were collected and assayed
for the presence of micronuclei. Thiocyclam did not cause any increase in the incidence of micro-
nucleated polychromatic erythrocytes in rats bone marrow at any of the dose levels. The polychro-
matic erythrocytes/normochromatic erythrocytes (PCE:NCE) ratio was found to be in the range
from 0.50 ± 0.11 to 0.55 ± 0.02. The results of this study demonstrate that the effect of thiocyclam
is not signiﬁcant in the rat in vivo micronucleus assay.
ª 2010 King Saud University. All rights reserved.1. Introduction
Mutation occurs spontaneously or under the inﬂuence of exter-
nal factors, such as a broad spectrum of chemicals, including
pharmaceutical, pesticides, and petroleum products, that are
present in the air we breathe, the water we drink, the foodhoo.com (M.A.A. Sarhan).
ity. All rights reserved. Peer-
d University.
lsevierwe eat and the region in which we work and live (WHO,
1985, 1992). Therefore, monitoring and evaluating the activi-
ties of the mutagenic substances in the environment are impor-
tant, as they often induce genotoxicity. The purposes of
genotoxicity testing are to assess the mutagenicity of chemi-
cals, in order to protect the human gene pool and to identify
potential carcinogens (Vanhauwaert et al., 2001).
Pesticides are agents used to kill or control undesired pests,
such as insects, weeds, rodents, fungi, bacteria or other organ-
isms. Until recently, pesticides were not considered a problem.
On the contrary, the use of these compounds was considered to
have a vital role in controlling agricultural and a sign of pro-
gress and modernization. With this attitude an increase use
of pesticides among the agricultural establishment, farmers’
was observed. Unfortunately, this increase has not been
accompanied by a full understanding of the potential risk
and possible adverse health effects to humans, domesticated
Figure 1 Structural formula of (a) thiocyclam (N,N-dimethyl-
1,2,3-trithian-5-amine) and (b) thiocyclam hydrogen oxalate.
312 K. Saleh et al.animals and the environment (Weiss et al., 2004). Since several
studies have shown that exposure to pesticides may are muta-
genic and induce genotoxic effects (Dulot et al., 1985; Garaj-
Vrhovac and Zeljezic, 2001, 2002; Leiss and Savitz, 1995; Zel-
jezic and Garaj-Vrhovac, 2004), the evaluation of the genotox-
icity of pesticides in use is of urgent concern.
The micronucleus assay using immature bone marrow
erythrocytes has been widely used as a simple and sensitive
short-term screening method in vivo for determining the muta-
genicity of chemical substances (Heddle, 1973, 1990; Heddle
et al., 1991; Schmid, 1975). Micronuclei arise from acentric
fragments, or whole chromosomes, that fail to incorporate into
the daughter nuclei during mitosis. Consequently, enumeration
of micronuclei in the cytoplasm of the interphase daughter cell
has been used to quantitate clastogenic or aneugenic chromo-
some DNA damage (Heddle, 1973; Schmid, 1975).
Currently, a lot of pesticides are used in Asser region
(South west region of Saudi Arabia) among them is thiocyclam
hydrogen oxalate (the trade name is Evisect; Figure 1). Thi-
ocyclam is a nereistoxin analogue insecticides, selective stom-
ach insecticide with contact action for lepidopterous and
coleopterous pests; some dipterous and thysanopterous pests.
Evisect was reported to have many side effects, including irri-
tating to skin and eyes, may cause sensitization by skin contact
and it is harmful if swallowed (Syngenta, 2001; Ware and
Whitacre, 2004). At low concentrations thiocyclam act as acet-
yl choline receptor agonists and as channel blockers at higher
concentrations (Ware and Whitacre, 2004). Evisect has not
been tested for mutagenicity, in this context; the current study
was conducted to provide additional data on the effect of thi-
ocyclam on induction of micronuclei in rat bone marrow cells.
2. Materials and methods
2.1. Test chemical and positive control
Thiocyclam (Evisect; CAS No.: 31895-22-4) was obtained
from the local market. Mitomycin C was obtained from Sigma
Chemical Company.
2.2. Animals
Young adult albino rats Rattus norvegicus were obtained from
the animal house at King Khalid University, Department of
Biological Sciences. Animals were about 2 months old and of
120–150 g weight. The animals were housed in a controlled
environment of temperature (22 C± 3). All animals were re-
ceived normal rat food and tap water ad libitum.2.3. Selection of dosage
The Syngenta Safety Data Sheet (Syngenta, 2001) showed that
the acute oral toxicity 540 mg/kg body weight is the LD50 in
rat for Evisect giving orally. In this study, 540 mg/kg body
weight was ﬁxed as the maximum dose. Subsequent dose levels
were ﬁxed at 50% and 25% of the LD50 values amounting to
270 mg/kg and 135 mg/kg body weight, respectively. Three
male mice were administered mitomycin C in normal saline
(10 ml/kg) by intraperitoneal injection at 0.75 mg/kg served
as positive controls.
2.4. Groups of animals under investigation and plan of
thiocyclam administration
In preliminary assay, a group of ﬁve male albino rats receiving
the maximum recommended dosage of thiocyclam. The ani-
mals were observed for clinical signs and symptoms for reac-
tions to treatment at 1, 4, 24 and 48 h. No clinical signs or
mortality was observed.
Animals were divided into four main groups (groups A–D)
and housed in four cages; each containing three rats. The trea-
ted groups were dosed by oral gavage once daily at 12 noon for
ﬁve consecutive days. The dose levels used were: Group A:
This group is the control animals received only the standard
diet and distilled water. Group B: Rats of this group received
thiocyclam (25% of the LD50 for 5 days in distilled water by
gavage). Group C: Rats of this group received thiocyclam
(50% of the LD50 for 5 days in distilled water by gavage).
Group D: Rats of this group received thiocyclam (LD50 for
5 days in distilled water by gavage). All animals were examined
immediately after each dose, approximately 1 h after each
dose, and at least daily for the duration of this assay for toxic
signs and/or mortality.
2.5. Micronucleus assay
At the end of the experimental period, animals (mice from each
of the treatment groups, and the positive control group) were
sacriﬁced by cervical dislocation at the morning of the next day
after the last injection. Both the femora were removed and
cleaned with gauze by removing all the adhering muscle and
tissue and subjected to micronucleus assay. The bone marrow
was ﬂushed out from both femurs using 1 mL of RPMI 1640
medium (bone marrow cells were pooled from both femurs
of each animal) and centrifuged at 1000 rpm for 10 min. the
cell were washed twice with phosphate buffered saline (PBS)
followed by centrifugation at 1000 rpm for 10 min. The super-
natant was removed by aspiration and the cells were ﬁxed in
cold 3:1 methanol:acetic acid. Slides were prepared by drop-
ping portions of the pellet on slides then air-dried for
20 min. Slides were stained with 5% solution of Giemsa in
0.01 M phosphate buffer at pH 7.4 according to the method
described by Schmid (1975) with slight modiﬁcations by Agar-
wal and Chauhan (1993). Three bone marrow smears per ani-
mal were prepared.
2.6. Scoring
The micronucleus frequency (expressed as percent micronucle-
ated cells) was determined by analyzing the number of micro-
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ech, 2000). The unit of scoring was the micronucleated cell, not
the micronucleus; thus, the occasional cell with more than one
micronucleus was counted as one micronucleated PCE. The
PCE:NCE ratio was calculated to evaluate the cytotoxic effect
of thiocyclam by scoring the number of PCEs and NCEs in
2000 cells per animal (Ouanes et al., 2003).
2.7. Statistical analysis
Micronucleus data were analyzed using Student’s t-test. Statis-
tical analysis was performed using SPSS/10.5 Software; p val-
ues of <0.05 were considered to indicate statistical
signiﬁcance. All results were expressed as mean ± SD for three
animals in each group.3. Results
Results obtained by the micronucleus analyses are summarized
in Table 1. In a preliminary assay involving a group of ﬁve
male albino rats receiving the maximum recommended dos-
ages of the thiocyclam, no mortality was observed after 48 h,
suggesting this is an adequate dosage for micronucleus induc-
tion evaluation.
The micronucleated polychromatic erythrocyte (MNPCEs)
in both investigated dose groups (135 and 270 mg/kg) were
8.0 ± 1.7 and 9.0 ± 1.0, respectively. When these data were
compared with control group they were not statistically signif-
icant. However, the highest dose of thiocyclam (540 mg/kg) in-
duces statistically signiﬁcant MnPCEs (p< 0.05). One
micronucleus was mainly observed at all dose levels but at high
concentration two micronuclei were observed in some poly-
chromatic cells. Mean number of MPCE per 2000 PE in posi-
tive controls receiving mitomycin C was signiﬁcantly
increased, suggesting that the test method was valid and the re-
sults were not an artefact.
The PCE:NCE ratio in groups treated with different doses
of thiocyclam range from 0.50 ± 0.11 to 0.55 ± 0.02, while
the PCE:NCE ratio in the group treated with mitomycin C
(positive control) was 0.41 ± 0.02.Table 1 Incidence of micronucleated polychromatic erythrocytes (M
Group
(control)
Dose
(mg/kg b.w.)
No. of
animals
MNPCEs/PCE scored
(individual data)
Mean ± S
A – 3 7/6000 (2,3,2) 2.3 ± 0.6
4/6000 (1,2,1) 1.3 ± 0.6
7/6000 (3,2,2) 2.7 ± 0.6
B 135 3 9/6000 (3,1,3) 1.6 ± 1.2
6/6000 (2,1,3) 2.0 ± 1.0
9/6000 (3,4,2) 3.0 ± 1.0
C 270 3 9/6000 (3,2,4) 3.0 ± 1.0
8/6000 (3,3,2) 2.6 ± 0.6
10/6000 (4,3,3) 3.3 ± 0.6
D 540 3 13/6000 (6,3,4) 4.3 ± 1.5
9/6000 (2,4,3) 3.0 ± 1.0
15/6000 (4,5,6) 5.0 ± 1.0
* p< 0.05.4. Discussion
In this in vivo study, the rat was chosen since rats are the most
widely used animals for general toxicologic, carcinogenic,
pharmacokinetic and toxico-kinetic studies. Many data are
available and would be useful for the overall assessment of
chemical substances (EPA, 1998). The oral route was selected
because it was the one route of exposure relevant to humans
that could maximize delivery of thiocyclam to the target tissue.
Gavage was used instead of drinking water to allow more pre-
cise dosing (Oller and Erexson, 2007).
Currently, the rat micronucleus assay is one of the methods
used to evaluate the genetic toxicity of chemicals in vivo. The
rodents (mouse and rat) bone marrow micronucleus test is
one of several available in vivo mammalian test system for
the detection of chromosomal aberrations (Morita et al.,
1997). In the last three decades, toxicologists have often used
the mouse and bone marrow micronucleus test since it has
advantages in speed, simplicity, and cost effectiveness in com-
parison to other in vivo systems for testing chromosomal aber-
rations (e.g. the cytogenetic test).
In the micronucleus formation, when a bone marrow eryth-
roblast develops into a polychromatic erythrocyte, the main
nucleus is extruded; any micronucleus that has been formed
may remain behind in the otherwise anucleated cytoplasm.
Visualization of micronuclei is facilitated in these cells because
they lack a main nucleus. An increase in the frequency of
micronucleated polychromatic erythrocytes in treated animals
is an indication of induced chromosome damage (Mavournin
et al., 1990; OECD 474, 1997).
A single sex study was considered adequate as extensive
studies of clastogens (chromosome breakage) by micronucleus
assay have led to the following conclusions: (1) any mouse and
rat strain is acceptable; (2) one sex, either male or female can
be used; (3) treatment by either intraperitoneal injection or
oral administration is acceptable; (4) examination 24–48 h
after a single administration of at least one dose will be accept-
able to evaluate the mutagenicity of chemicals (Sutou, 1996).
Though the micronuclei assay is very useful as a short-term
screening method. It is difﬁcult to evaluate the safety of chem-
ical substances based on only one short-term test system. It isNPCEs) in bone marrow of albino rats.
D Mean ± SD
(group data)
Frequency (%)
(individual data)
Frequency (%)
(group data)
PCE/NCE
6.0 ± 1.7 0.12 0.10 ± 0.03 0.55 ± 0.02
0.07
0.12
8.0 ± 1.7 0.15 0.13 ± 0.03 0.50 ± 0.11
0.10
0.15
9.0 ± 1.0 0.15 0.15 ± 0.02 0.51 ± 0.05
0.13
0.16
12.3 ± 3.1* 0.21 0.20 ± 0.05* 0.54 ± 0.10
0.15
0.25
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chemical substances that the in vitro bacterial reverse mutation
assay (Ames test), in vitro mammalian cells chromosome
abnormal test and in vivo rodent micronucleus assay should
be used, as in the series. The in vivo micronucleus assay in bone
marrow cells is used to identify chromosome aberration, thus
the target cells must be effectively exposed to the chemical stuff
tested (Sato and Tomitab, 2001). However, the bone marrow
micronucleus assay may not be suitable for clastogenic com-
pounds, which are reactive to other cellular molecules and
have barrier for reaching bone marrow cells (Sato and Tomi-
tab, 2001). The compounds administered orally, intraperitone-
ally or intravenously may be inactivated before it reaches the
target bone marrow cells. Thus, a micronucleus assay using
other organs or tissue.
The number of MNPCEs in the positive control receiving
mitomycin C showed signiﬁcant increase compared to the neg-
ative control. This ﬁnding demonstrate the validity of the
experiment and the sensitivity of the animal strain to the clas-
togenic agents as observe by Krishna and Hyashi (2000).
The results of this study clearly demonstrate that thiocy-
clam does not induce micronuclei formation in bone marrow
cells after different gavage doses to albino rats. Thus, thiocy-
clam does not act as a genotoxic material based on the avail-
able in vitro and in vivo data. Our results are in agreement
with the WHO and the Health Effects Division Ofﬁce of Pes-
ticide Programs US Environmental Protection Agency that
considered thiocyclam as moderately hazardous pesticide and
not carcinogenic to human (EPA, 2006; WHO, 2005).
The PCE:NCE ratio is used to evaluate the cytotoxicity and
heavy DNA damages leading to cell death or apoptosis
(Ouanes et al., 2003). The analysis of the PCE:NCE ratio at
different doses of thiocyclam showed that animal groups trea-
ted had a ratio close to the values reported for mice in litera-
ture that is between 0.5 and 1.0 (Adler, 1984), these results
showed that the thiocyclam is not genotoxic.
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